139 related articles for article (PubMed ID: 37102221)
1. Survival in elderly patients with breast cancer with and without autoimmune disease.
Dedousis D; Zhang AL; Vassiliou AN; Cao S; Yammani D; Kyasaram RK; Shanahan JP; Keinath MC; Hsu ML; Fu P; Dowlati A; Montero AJ
Cancer Med; 2023 Jun; 12(12):13086-13099. PubMed ID: 37102221
[TBL] [Abstract][Full Text] [Related]
2. Autoimmune diseases and breast cancer risk by tumor hormone-receptor status among elderly women.
Schairer C; Pfeiffer RM; Gadalla SM
Int J Cancer; 2018 Mar; 142(6):1202-1208. PubMed ID: 29144542
[TBL] [Abstract][Full Text] [Related]
3. Comparing Survival in Patients With Lung Cancer With and Without a History of Common Autoimmune Disease.
Dedousis D; Vassiliou AN; Cao S; Yammani D; Kyasaram RK; Shanahan J; Keinath MC; Zhang AL; Hsu ML; Fu P; Dowlati A
JTO Clin Res Rep; 2022 Sep; 3(9):100375. PubMed ID: 35992245
[TBL] [Abstract][Full Text] [Related]
4. How does autoimmune disease impact treatment and outcomes among patients with lung cancer? A national SEER-Medicare analysis.
Khan SA; Pruitt SL; Xuan L; Makris U; Gerber DE
Lung Cancer; 2018 Jan; 115():97-102. PubMed ID: 29290269
[TBL] [Abstract][Full Text] [Related]
5. Clinical and economic burden associated with stage III to IV triple-negative breast cancer: A SEER-Medicare historical cohort study in elderly women in the United States.
Schwartz KL; Simon MS; Bylsma LC; Ruterbusch JJ; Beebe-Dimmer JL; Schultz NM; Flanders SC; Barlev A; Fryzek JP; Quek RGW
Cancer; 2018 May; 124(10):2104-2114. PubMed ID: 29505670
[TBL] [Abstract][Full Text] [Related]
6. Effect of Age on Breast Cancer Patient Prognoses: A Population-Based Study Using the SEER 18 Database.
Chen HL; Zhou MQ; Tian W; Meng KX; He HF
PLoS One; 2016; 11(10):e0165409. PubMed ID: 27798652
[TBL] [Abstract][Full Text] [Related]
7. Comparative Effectiveness of Chemotherapy Regimens in Prolonging Survival for Two Large Population-Based Cohorts of Elderly Adults with Breast and Colon Cancer in 1992-2009.
Du XL; Zhang Y; Parikh RC; Lairson DR; Cai Y
J Am Geriatr Soc; 2015 Aug; 63(8):1570-82. PubMed ID: 26200214
[TBL] [Abstract][Full Text] [Related]
8. Survival, healthcare resource use and costs among stage IV ER + breast cancer patients not receiving HER2 targeted therapy: a retrospective analysis of linked SEER-Medicare data.
Lang K; Huang H; Sasane M; Paly VF; Hao Y; Menzin J
BMC Health Serv Res; 2014 Jul; 14():298. PubMed ID: 25008431
[TBL] [Abstract][Full Text] [Related]
9. Analysis of Sociodemographic, Clinical, and Genomic Factors Associated With Breast Cancer Mortality in the Linked Surveillance, Epidemiology, and End Results and Medicare Database.
Robinson TJ; Wilson LE; Marcom PK; Troester M; Lynch CF; Hernandez BY; Parrilla E; Brauer HA; Dinan MA
JAMA Netw Open; 2021 Oct; 4(10):e2131020. PubMed ID: 34714340
[TBL] [Abstract][Full Text] [Related]
10. Characterizing Autoimmune Disease-associated Diffuse Large B-cell Lymphoma in a SEER-Medicare Cohort.
Koff JL; Rai A; Flowers CR
Clin Lymphoma Myeloma Leuk; 2018 Feb; 18(2):e115-e121. PubMed ID: 29273217
[TBL] [Abstract][Full Text] [Related]
11. Severity of comorbid conditions and early-stage breast cancer therapy: linked SEER-Medicare data from 1993 to 2005.
Yasmeen S; Chlebowski RT; Xing G; Morris CR; Romano PS
Cancer Med; 2013 Aug; 2(4):526-36. PubMed ID: 24156025
[TBL] [Abstract][Full Text] [Related]
12. Stage at diagnosis and treatment patterns among older women with breast cancer: an HMO and fee-for-service comparison.
Riley GF; Potosky AL; Klabunde CN; Warren JL; Ballard-Barbash R
JAMA; 1999 Feb; 281(8):720-6. PubMed ID: 10052442
[TBL] [Abstract][Full Text] [Related]
13. Comparison of treatment of early-stage breast cancer among Nurses' Health Study participants and other Medicare beneficiaries.
Austin AM; Kapadia NS; Brooks GA; Onega TL; Eliassen AH; Tamimi RM; Holmes M; Wang Q; Grodstein F; Tosteson ANA
Breast Cancer Res Treat; 2019 Apr; 174(3):759-767. PubMed ID: 30607634
[TBL] [Abstract][Full Text] [Related]
14. Limited validity of diagnosis codes in Medicare claims for identifying cancer metastases and inferring stage.
Chawla N; Yabroff KR; Mariotto A; McNeel TS; Schrag D; Warren JL
Ann Epidemiol; 2014 Sep; 24(9):666-72, 672.e1-2. PubMed ID: 25066409
[TBL] [Abstract][Full Text] [Related]
15. The influence of comorbidities on overall survival among older women diagnosed with breast cancer.
Patnaik JL; Byers T; Diguiseppi C; Denberg TD; Dabelea D
J Natl Cancer Inst; 2011 Jul; 103(14):1101-11. PubMed ID: 21719777
[TBL] [Abstract][Full Text] [Related]
16. Mammography use, breast cancer stage at diagnosis, and survival among older women.
McCarthy EP; Burns RB; Freund KM; Ash AS; Shwartz M; Marwill SL; Moskowitz MA
J Am Geriatr Soc; 2000 Oct; 48(10):1226-33. PubMed ID: 11037009
[TBL] [Abstract][Full Text] [Related]
17. Association between adjuvant chemotherapy and risk of acute kidney injury in elderly women diagnosed with early-stage breast cancer.
Li S; Liu J; Virnig BA; Collins AJ
Breast Cancer Res Treat; 2017 Feb; 161(3):515-524. PubMed ID: 27933451
[TBL] [Abstract][Full Text] [Related]
18. Racial and ethnic differences in breast cancer survival: how much is explained by screening, tumor severity, biology, treatment, comorbidities, and demographics?
Curtis E; Quale C; Haggstrom D; Smith-Bindman R
Cancer; 2008 Jan; 112(1):171-80. PubMed ID: 18040998
[TBL] [Abstract][Full Text] [Related]
19. Survival among Breast Cancer Patients: Comparison of the U.S. Military Health System with the Surveillance, Epidemiology and End Results Program.
Lin J; Hu H; Shriver CD; Zhu K
Clin Breast Cancer; 2022 Jun; 22(4):e506-e516. PubMed ID: 34961733
[TBL] [Abstract][Full Text] [Related]
20. Association Between Use of the 21-Gene Recurrence Score Assay and Receipt of Chemotherapy Among Medicare Beneficiaries With Early-Stage Breast Cancer, 2005-2009.
Dinan MA; Mi X; Reed SD; Lyman GH; Curtis LH
JAMA Oncol; 2015 Nov; 1(8):1098-109. PubMed ID: 26313372
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
